These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 23566849)

  • 21. Analysis of mucolipidosis II/III GNPTAB missense mutations identifies domains of UDP-GlcNAc:lysosomal enzyme GlcNAc-1-phosphotransferase involved in catalytic function and lysosomal enzyme recognition.
    Qian Y; van Meel E; Flanagan-Steet H; Yox A; Steet R; Kornfeld S
    J Biol Chem; 2015 Jan; 290(5):3045-56. PubMed ID: 25505245
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prenatal skeletal dysplasia phenotype in severe MLII alpha/beta with novel GNPTAB mutation.
    Aggarwal S; Coutinho MF; Dalal AB; Mohamed Nurul Jain SJ; Prata MJ; Alves S
    Gene; 2014 Jun; 542(2):266-8. PubMed ID: 24685522
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Disease-causing missense mutations within the N-terminal transmembrane domain of GlcNAc-1-phosphotransferase impair endoplasmic reticulum translocation or Golgi retention.
    Lee WS; Jennings BC; Doray B; Kornfeld S
    Hum Mutat; 2020 Jul; 41(7):1321-1328. PubMed ID: 32220096
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular characterization of 22 novel UDP-N-acetylglucosamine-1-phosphate transferase alpha- and beta-subunit (GNPTAB) gene mutations causing mucolipidosis types IIalpha/beta and IIIalpha/beta in 46 patients.
    Tappino B; Chuzhanova NA; Regis S; Dardis A; Corsolini F; Stroppiano M; Tonoli E; Beccari T; Rosano C; Mucha J; Blanco M; Szlago M; Di Rocco M; Cooper DN; Filocamo M
    Hum Mutat; 2009 Nov; 30(11):E956-73. PubMed ID: 19634183
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mucolipidosis II and III alpha/beta: mutation analysis of 40 Japanese patients showed genotype-phenotype correlation.
    Otomo T; Muramatsu T; Yorifuji T; Okuyama T; Nakabayashi H; Fukao T; Ohura T; Yoshino M; Tanaka A; Okamoto N; Inui K; Ozono K; Sakai N
    J Hum Genet; 2009 Mar; 54(3):145-51. PubMed ID: 19197337
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of an Antisense Oligonucleotide-Mediated Exon Skipping Therapeutic Strategy for Mucolipidosis II: Validation at RNA Level.
    Matos L; Vilela R; Rocha M; Santos JI; Coutinho MF; Gaspar P; Prata MJ; Alves S
    Hum Gene Ther; 2020 Jul; 31(13-14):775-783. PubMed ID: 32283951
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dilated cardiomyopathy in mucolipidosis type 2.
    Carboni E; Sestito S; Lucente M; Morrone A; Zampini L; Chimenz R; Ceravolo MD; De Sarro R; Ceravolo G; Calabrò MP; Parisi F; Moricca MT; Pensabene L; Musolino D; Concolino D
    J Biol Regul Homeost Agents; 2020; 34(4 Suppl. 2):71-77. SPECIAL ISSUE: FOCUS ON PEDIATRIC CARDIOLOGY. PubMed ID: 33000604
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enigmatic in vivo GlcNAc-1-phosphotransferase (GNPTG) transcript correction to wild type in two mucolipidosis III gamma siblings homozygous for nonsense mutations.
    Velho RV; Ludwig NF; Alegra T; Sperb-Ludwig F; Guarany NR; Matte U; Schwartz IV
    J Hum Genet; 2016 Jun; 61(6):555-60. PubMed ID: 26935170
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phenotype and genotype in mucolipidoses II and III alpha/beta: a study of 61 probands.
    Cathey SS; Leroy JG; Wood T; Eaves K; Simensen RJ; Kudo M; Stevenson RE; Friez MJ
    J Med Genet; 2010 Jan; 47(1):38-48. PubMed ID: 19617216
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutation Analysis of 16 Mucolipidosis II and III Alpha/Beta Chinese Children Revealed Genotype-Phenotype Correlations.
    Liu S; Zhang W; Shi H; Yao F; Wei M; Qiu Z
    PLoS One; 2016; 11(9):e0163204. PubMed ID: 27662472
    [TBL] [Abstract][Full Text] [Related]  

  • 31. AAV8-mediated expression of N-acetylglucosamine-1-phosphate transferase attenuates bone loss in a mouse model of mucolipidosis II.
    Ko AR; Jin DK; Cho SY; Park SW; Przybylska M; Yew NS; Cheng SH; Kim JS; Kwak MJ; Kim SJ; Sohn YB
    Mol Genet Metab; 2016 Apr; 117(4):447-55. PubMed ID: 26857995
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular analysis of cell lines from patients with mucolipidosis II and mucolipidosis III.
    Zarghooni M; Dittakavi SS
    Am J Med Genet A; 2009 Dec; 149A(12):2753-61. PubMed ID: 19938078
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pathogenic variants in GNPTAB and GNPTG encoding distinct subunits of GlcNAc-1-phosphotransferase differentially impact bone resorption in patients with mucolipidosis type II and III.
    Di Lorenzo G; Westermann LM; Yorgan TA; Stürznickel J; Ludwig NF; Ammer LS; Baranowsky A; Ahmadi S; Pourbarkhordariesfandabadi E; Breyer SR; Board TN; Foster A; Mercer J; Tylee K; Velho RV; Schweizer M; Renné T; Braulke T; Randon DN; Sperb-Ludwig F; de Camargo Pinto LL; Moreno CA; Cavalcanti DP; Amling M; Kutsche K; Winter D; Muschol NM; Schwartz IVD; Rolvien T; Danyukova T; Schinke T; Pohl S
    Genet Med; 2021 Dec; 23(12):2369-2377. PubMed ID: 34341521
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Compensatory expression of human N-acetylglucosaminyl-1-phosphotransferase subunits in mucolipidosis type III gamma.
    Pohl S; Tiede S; Castrichini M; Cantz M; Gieselmann V; Braulke T
    Biochim Biophys Acta; 2009 Mar; 1792(3):221-5. PubMed ID: 19708128
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A GNPTAB nonsense variant is associated with feline mucolipidosis II (I-cell disease).
    Wang P; Mazrier H; Caverly Rae J; Raj K; Giger U
    BMC Vet Res; 2018 Dec; 14(1):416. PubMed ID: 30591066
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An Alu insertion in compound heterozygosity with a microduplication in GNPTAB gene underlies Mucolipidosis II.
    Tappino B; Regis S; Corsolini F; Filocamo M
    Mol Genet Metab; 2008 Feb; 93(2):129-33. PubMed ID: 17964840
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mucolipidosis II: a single causal mutation in the N-acetylglucosamine-1-phosphotransferase gene (GNPTAB) in a French Canadian founder population.
    Plante M; Claveau S; Lepage P; Lavoie EM; Brunet S; Roquis D; Morin C; Vézina H; Laprise C
    Clin Genet; 2008 Mar; 73(3):236-44. PubMed ID: 18190596
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification and molecular characterization of six novel mutations in the UDP-N-acetylglucosamine-1-phosphotransferase gamma subunit (GNPTG) gene in patients with mucolipidosis III gamma.
    Persichetti E; Chuzhanova NA; Dardis A; Tappino B; Pohl S; Thomas NS; Rosano C; Balducci C; Paciotti S; Dominissini S; Montalvo AL; Sibilio M; Parini R; Rigoldi M; Di Rocco M; Parenti G; Orlacchio A; Bembi B; Cooper DN; Filocamo M; Beccari T
    Hum Mutat; 2009 Jun; 30(6):978-84. PubMed ID: 19370764
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A novel compound heterozygous mutation of GNPTAB gene underlying a case with mucolipidosis type II α/β].
    Yang K; Lou G; Qi N; Zhang Y; Zhu H; Wang L; Wang X; Zhang B
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2019 Jun; 36(6):606-609. PubMed ID: 31055817
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical and genetic analysis of mucolipidosis in 3 pedigrees and literature review].
    Liu N; Feng Y; Jiang M; Kong XD
    Zhonghua Er Ke Za Zhi; 2019 Dec; 57(12):950-954. PubMed ID: 31795562
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.